ATE288423T1 - Benzoesäureester von oxazolidinonen, die hydroxyacetylpiperazin-gruppen tragen - Google Patents

Benzoesäureester von oxazolidinonen, die hydroxyacetylpiperazin-gruppen tragen

Info

Publication number
ATE288423T1
ATE288423T1 AT00980849T AT00980849T ATE288423T1 AT E288423 T1 ATE288423 T1 AT E288423T1 AT 00980849 T AT00980849 T AT 00980849T AT 00980849 T AT00980849 T AT 00980849T AT E288423 T1 ATE288423 T1 AT E288423T1
Authority
AT
Austria
Prior art keywords
hydroxyacetylpiperazine
oxazolidinones
bearing
groups
benzoic acid
Prior art date
Application number
AT00980849T
Other languages
English (en)
Inventor
Jackson B Hester Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE288423T1 publication Critical patent/ATE288423T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00980849T 1999-12-14 2000-12-06 Benzoesäureester von oxazolidinonen, die hydroxyacetylpiperazin-gruppen tragen ATE288423T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17067599P 1999-12-14 1999-12-14
PCT/US2000/032432 WO2001044212A1 (en) 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent

Publications (1)

Publication Number Publication Date
ATE288423T1 true ATE288423T1 (de) 2005-02-15

Family

ID=22620832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00980849T ATE288423T1 (de) 1999-12-14 2000-12-06 Benzoesäureester von oxazolidinonen, die hydroxyacetylpiperazin-gruppen tragen

Country Status (26)

Country Link
US (1) US6281210B1 (de)
EP (1) EP1242395B1 (de)
JP (1) JP2003516977A (de)
KR (1) KR20020062332A (de)
CN (1) CN1390211A (de)
AR (1) AR026547A1 (de)
AT (1) ATE288423T1 (de)
AU (1) AU1805801A (de)
BR (1) BR0015177A (de)
CA (1) CA2387047A1 (de)
CO (1) CO5261527A1 (de)
CZ (1) CZ20022389A3 (de)
DE (1) DE60017941T2 (de)
EA (1) EA200200673A1 (de)
ES (1) ES2236006T3 (de)
HU (1) HUP0203787A3 (de)
IL (1) IL150031A0 (de)
MX (1) MXPA02005909A (de)
NO (1) NO20022811L (de)
PE (1) PE20010851A1 (de)
PL (1) PL355369A1 (de)
PT (1) PT1242395E (de)
SK (1) SK5972002A3 (de)
TW (1) TW544449B (de)
WO (1) WO2001044212A1 (de)
ZA (1) ZA200202953B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
ATE321024T1 (de) * 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
ATE344036T1 (de) * 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (de) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prophylaxe und Behandlung von thrombolischen Erkrankungen
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
WO2007039132A1 (de) 2005-10-04 2007-04-12 Bayer Healthcare Ag Neue polymorphe form und die amorphe form von 5-chlor-n- ( { ( 5s ) -2-0x0-3-[4-( 3-oxo-4-morpholinyl) - phenyl] -1,3-oxazolidin-5-yl} -methyl) -2- thiophencarboxamid
US20100210602A1 (en) * 2006-12-12 2010-08-19 The Johns Hopkins University PhoU (PerF), A PERSISTENCE SWITCH INVOLVED IN PERSISTER FORMATION AND TOLERANCE TO MULTIPLE ANTIBIOTICS AND STRESSES AS A DRUG TARGET FOR PERSISTER BACTERIA
WO2009001192A2 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ274966A (en) * 1993-11-22 1998-01-26 Upjohn Co Substituted-hydroxyacetyl piperazine phenyl oxazolidinone derivatives, use in pharmaceutical compositions
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
FI19992555A7 (fi) * 1997-05-30 1999-11-30 Upjohn Co Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
AU1805801A (en) 2001-06-25
AR026547A1 (es) 2003-02-19
ES2236006T3 (es) 2005-07-16
PE20010851A1 (es) 2001-08-17
WO2001044212A1 (en) 2001-06-21
EP1242395A1 (de) 2002-09-25
US6281210B1 (en) 2001-08-28
IL150031A0 (en) 2002-12-01
SK5972002A3 (en) 2003-01-09
CO5261527A1 (es) 2003-03-31
KR20020062332A (ko) 2002-07-25
PL355369A1 (en) 2004-04-19
MXPA02005909A (es) 2002-10-23
CZ20022389A3 (cs) 2002-10-16
CA2387047A1 (en) 2001-06-21
TW544449B (en) 2003-08-01
BR0015177A (pt) 2002-06-18
DE60017941D1 (de) 2005-03-10
CN1390211A (zh) 2003-01-08
NO20022811D0 (no) 2002-06-13
NO20022811L (no) 2002-06-13
PT1242395E (pt) 2005-05-31
EP1242395B1 (de) 2005-02-02
HUP0203787A2 (hu) 2003-07-28
HUP0203787A3 (en) 2005-06-28
EA200200673A1 (ru) 2002-12-26
DE60017941T2 (de) 2006-03-30
JP2003516977A (ja) 2003-05-20
ZA200202953B (en) 2003-09-23

Similar Documents

Publication Publication Date Title
DE60017941D1 (de) Benzoesäureester von oxazolidinonen, die hydroxyacetylpiperazin-gruppen tragen
NO20022728L (no) Nye aminopropylfosfinsyrer
EE200200130A (et) Uued farmatseutiliste omadustega aminodikarboksüülhappe derivaadid
CY2008009I1 (el) 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειικο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας
DE60015430D1 (de) Lager
NO20031797L (no) Heteroarylalkylpiperazin-derivater som fettsyreoksidasjonsinhibitorer
ATE273288T1 (de) 2,3,4,5-tetrahydro-1h-(1,4)benzodiazepin-3- hydroxamsäure als matrix metalloproteinaseinhibitoren
ATE326536T1 (de) Herstellung von biologisch aktiven molekülen
DZ3155A1 (fr) Nouvelle composition pharmaceutique.
DE60043730D1 (de) Arylsulfonamid-substituierte hydroxamsäure-derivate
DE60013021D1 (de) Herstellung von S,S und R,S Aminosäuren-Isosteren
EE200100708A (et) Asendatud fenoksüäädikhapped
ID26379A (id) Katalis asam padat
DE60127209D1 (de) Quaternäre fettsäure auf basis von anti-iso verbindungen
EP1352072A4 (de) Formulierungen für die zuführung von nukleinsäuren
DE60019507D1 (de) Wässrige Dispersionen von Percarbonsäure
BR0000986B1 (pt) método para a produção de ácido (met) acrìlico e/ou ésteres (met) acrìlicos.
DE69912854D1 (de) Hydrierung von phthalsäuren
NO20014787D0 (no) Fremgangsmåte for fremstilling av hydroksymetyltiosmörsyre- estere
DZ3163A1 (fr) Nouvelle substance pharmaceutique.
DE60036758D1 (de) Verfahren zur Herstellung von optisch aktiver 3,3,3-Trifluor-2-hydroxy-2-methylpropionsäure und deren Salze
DE60010725D1 (de) Herstellung von arylcarbonsäureestern
IT1320116B1 (it) Macchina per la etichettatura di oggetti.
NO953322L (no) Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler
ATE212975T1 (de) Carbamoylcarbonsäureamidoxime

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1242395

Country of ref document: EP

REN Ceased due to non-payment of the annual fee